07/11/2019
3:43 PM | Onconova Therapeutics (Issuer)
TYNDALL CAPITAL PARTNERS L P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities |  |
07/01/2019
3:35 PM | Onconova Therapeutics (Issuer)
TYNDALL CAPITAL PARTNERS L P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2019
3:21 PM | Onconova Therapeutics (Issuer)
TYNDALL CAPITAL PARTNERS L P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/19/2019
3:05 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2019
7:38 PM | Onconova Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
05/24/2019
4:15 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2019
11:15 PM | Onconova Therapeutics (Filer)
| Form EFFECT
| |
05/17/2019
4:13 PM | Onconova Therapeutics (Filer)
| Form S-3/A
| |
05/17/2019
3:37 PM | Onconova Therapeutics (Filer)
| Form 424B2
| |
05/16/2019
3:04 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2019
7:15 AM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2019
3:45 PM | Onconova Therapeutics (Filer)
| Form DEF 14A
| |
04/08/2019
6:19 PM | Maniar Manoj (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2019
3:40 PM | Onconova Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/01/2019
3:48 PM | Onconova Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2019
6:55 AM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2019
10:26 AM | Onconova Therapeutics (Subject)
TYNDALL CAPITAL PARTNERS L P (Filed by)
| Form SC 13G/A
| |
02/14/2019
1:55 PM | ARMISTICE CAPITAL, LLC (Filed by)
Onconova Therapeutics (Subject)
| Form SC 13G/A
| |
02/14/2019
1:37 PM | EcoR1 Capital, LLC (Filed by)
Onconova Therapeutics (Subject)
| Form SC 13G/A
| |
01/15/2019
4:15 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2019
12:02 PM | Onconova Therapeutics (Subject)
SABBY MANAGEMENT, LLC (Filed by)
| Form SC 13G/A
| |
12/14/2018
5:15 PM | OLER ABRAHAM N. (Reporting)
Onconova Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/03/2018
7:08 AM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2018
4:01 PM | Onconova Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2018
7:30 AM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2018
4:10 PM | Onconova Therapeutics (Issuer)
Woodman Richard Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2018
4:07 PM | Onconova Therapeutics (Issuer)
Woodman Richard Charles (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/15/2018
7:55 AM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2018
3:46 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2018
4:22 PM | Hoffman Michael B (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2018
4:21 PM | Onconova Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2018
7:30 AM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2018
4:34 PM | Hoffman Michael B (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2018
4:32 PM | MARINO JAMES J (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2018
4:31 PM | Onconova Therapeutics (Issuer)
STOVER JACK E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2018
4:30 PM | MEHTA VIREN (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2018
4:29 PM | Onconova Therapeutics (Issuer)
Reddy E Premkumar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2018
4:28 PM | GROOPMAN JEROME (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2018
4:26 PM | Guerin Mark Patrick (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2018
4:25 PM | Kumar Ramesh (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2018
4:24 PM | Fruchtman Steven M (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2018
4:23 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2018
4:23 PM | Maniar Manoj (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/27/2018
2:46 PM | Hoffman Michael B (Filed by)
Onconova Therapeutics (Subject)
| Form SC 13D/A
| |
07/16/2018
5:47 PM | Onconova Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/29/2018
3:45 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2018
7:13 AM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/08/2018
4:15 PM | Onconova Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
06/08/2018
10:13 AM | Onconova Therapeutics (Filer)
| Form DEF 14A
| |
06/08/2018
6:00 AM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2018
9:41 AM | Onconova Therapeutics (Filer)
| Form CT ORDER
| |
05/31/2018
4:27 PM | Bienen Henry S (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2018
7:03 AM | Onconova Therapeutics (Filer)
| Form PRE 14A
| |
05/17/2018
4:23 PM | Onconova Therapeutics (Filer)
| Form DEF 14A
| |
05/15/2018
3:32 PM | Onconova Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2018
3:06 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2018
8:00 AM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2018
3:06 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2018
4:09 PM | Onconova Therapeutics (Filer)
| Form PRE 14A
| |
05/07/2018
3:47 PM | EcoR1 Capital, LLC (Filed by)
Onconova Therapeutics (Subject)
| Form SC 13G
| |
05/04/2018
3:05 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2018
1:44 PM | 683 Capital Management, LLC (Reporting)
683 Capital Partners, LP (Reporting)
Onconova Therapeutics (Issuer)
Zweiman Ari (Reporting)
| Form 3/A
| |
05/01/2018
5:35 PM | Onconova Therapeutics (Issuer)
Reddy E Premkumar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2018
5:34 PM | Hoffman Michael B (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2018
5:30 PM | Onconova Therapeutics (Issuer)
STOVER JACK E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2018
5:28 PM | MARINO JAMES J (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2018
4:18 PM | 683 Capital Management, LLC (Filed by)
Onconova Therapeutics (Subject)
| Form SC 13D/A
| |
05/01/2018
4:14 PM | 683 Capital Management, LLC (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2018
3:12 PM | Onconova Therapeutics (Issuer)
TYNDALL CAPITAL PARTNERS L P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2018
3:07 PM | Onconova Therapeutics (Filer)
| Form 424B3
| |
04/30/2018
7:52 AM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2018
7:50 AM | Onconova Therapeutics (Filer)
| Form 424B4
| |
04/26/2018
11:15 PM | Onconova Therapeutics (Filer)
| Form EFFECT
| |
04/26/2018
3:05 PM | Onconova Therapeutics (Filer)
| Form S-1/A
| |
04/25/2018
4:04 PM | Onconova Therapeutics (Filer)
| Form S-1/A
| |
04/25/2018
3:19 PM | Onconova Therapeutics (Filer)
| Form 10-K/A
| |
04/25/2018
5:08 AM | Onconova Therapeutics (Filer)
| Form S-1/A
| |
04/23/2018
4:20 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2018
3:05 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2018
4:31 PM | Onconova Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/22/2018
3:05 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2018
4:00 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2018
7:43 AM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2018
7:00 AM | Onconova Therapeutics (Filer)
| Form DEF 14A
| |
02/27/2018
4:26 PM | Kumar Ramesh (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2018
3:35 PM | Onconova Therapeutics (Subject)
Reddy E Premkumar (Filed by)
| Form SC 13D/A
| |
02/20/2018
4:04 PM | ARMISTICE CAPITAL, LLC (Filed by)
Onconova Therapeutics (Subject)
| Form SC 13G
| |
02/16/2018
4:24 PM | 683 Capital Management, LLC (Filed by)
Onconova Therapeutics (Subject)
| Form SC 13D
| |
02/16/2018
4:07 PM | 683 Capital Management, LLC (Reporting)
Onconova Therapeutics (Issuer)
| Form 3/A
| |
02/16/2018
4:07 PM | Onconova Therapeutics (Filer)
| Form PRE 14A
| |
02/16/2018
4:06 PM | 683 Capital Management, LLC (Filed by)
Onconova Therapeutics (Subject)
| Form SC 13D/A
| |
02/14/2018
3:09 PM | Onconova Therapeutics (Subject)
TYNDALL CAPITAL PARTNERS L P (Filed by)
| Form SC 13G/A
| |
02/12/2018
6:12 PM | Onconova Therapeutics (Issuer)
TYNDALL CAPITAL PARTNERS L P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2018
4:20 PM | MARINO JAMES J (Reporting)
Onconova Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2018
4:19 PM | Onconova Therapeutics (Filer)
| Form 424B4
| |
02/08/2018
7:52 AM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2018
11:15 PM | Onconova Therapeutics (Filer)
| Form EFFECT
| |
02/05/2018
8:26 PM | Onconova Therapeutics (Filer)
| Form S-1/A
| |
02/05/2018
8:20 PM | Onconova Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2018
7:27 AM | Onconova Therapeutics (Filer)
| Form S-1/A
| |
